Transgene Biotek Limited (TRABI.BO)

INR 7.34

(-0.53%)

Operating Expenses Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual operating expenses in 2023 was 5.39 Million INR , down -89.96% from previous year.
Transgene Biotek Limited's latest quarterly operating expenses in 2024 Q1 was 4.61 Million INR , up 95.34% from previous quarter.
Transgene Biotek Limited reported a annual operating expenses of 53.73 Million INR in annual operating expenses 2022, down -48.04% from previous year.
Transgene Biotek Limited reported a annual operating expenses of 103.42 Million INR in annual operating expenses 2021, down -0.2% from previous year.
Transgene Biotek Limited reported a quarterly operating expenses of 5.39 Million INR for 2023 FY, down -89.96% from previous quarter.
Transgene Biotek Limited reported a quarterly operating expenses of 1.88 Million INR for 2023 Q2, down -24.49% from previous quarter.

Annual Operating Expenses Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual Operating Expenses of Transgene Biotek Limited (2023 - 2006)

Year	Operating Expenses	Operating Expenses Growth
2023	5.39 Million INR	-89.96%
2022	53.73 Million INR	-48.04%
2021	103.42 Million INR	-0.2%
2020	103.63 Million INR	-1.95%
2019	105.7 Million INR	2.05%
2018	103.58 Million INR	0.95%
2017	102.6 Million INR	-43.26%
2016	180.82 Million INR	-17.11%
2015	218.14 Million INR	14.32%
2014	190.81 Million INR	0.52%
2013	189.83 Million INR	641.81%
2012	25.59 Million INR	118.94%
2011	-135.13 Million INR	-481.94%
2010	35.38 Million INR	88.5%
2009	18.76 Million INR	-0.19%
2008	18.8 Million INR	15.87%
2007	16.22 Million INR	421.35%
2006	3.11 Million INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	4.61 Million INR	95.34%
2023 FY	5.39 Million INR	-89.96%
2023 Q2	1.88 Million INR	-24.49%
2023 Q1	2.5 Million INR	-69.31%
2023 Q4	2.36 Million INR	211.48%
2023 Q3	758 Thousand INR	-59.89%
2022 FY	53.73 Million INR	-48.04%
2022 Q2	17.67 Million INR	22.65%
2022 Q3	13.49 Million INR	-23.65%
2022 Q1	14.41 Million INR	-43.38%
2022 Q4	8.15 Million INR	-39.57%
2021 Q4	25.45 Million INR	-2.75%
2021 Q1	25.92 Million INR	5.01%
2021 FY	103.42 Million INR	-0.2%
2021 Q3	26.16 Million INR	1.08%
2021 Q2	25.89 Million INR	-0.13%
2020 FY	103.63 Million INR	-1.95%
2020 Q1	26.09 Million INR	0.08%
2020 Q2	26.41 Million INR	1.2%
2020 Q3	26.51 Million INR	0.37%
2020 Q4	24.68 Million INR	-6.88%
2019 FY	105.7 Million INR	2.05%
2019 Q4	26.08 Million INR	-0.63%
2019 Q3	26.24 Million INR	-3.08%
2019 Q2	27.07 Million INR	2.96%
2019 Q1	26.29 Million INR	5.36%
2018 Q4	24.96 Million INR	-6.45%
2018 FY	103.58 Million INR	0.95%
2018 Q3	26.68 Million INR	3.01%
2018 Q2	25.9 Million INR	-0.5%
2018 Q1	26.03 Million INR	0.0%
2017 FY	102.6 Million INR	-43.26%
2016 FY	180.82 Million INR	-17.11%
2016 Q4	- INR	0.0%
2015 FY	218.14 Million INR	14.32%
2015 Q4	- INR	0.0%
2014 FY	190.81 Million INR	0.52%
2013 FY	189.83 Million INR	641.81%
2012 Q3	4.55 Million INR	-10.38%
2012 Q2	5.07 Million INR	-1.47%
2012 Q1	5.15 Million INR	0.0%
2012 FY	25.59 Million INR	118.94%
2012 Q4	11.41 Million INR	150.79%
2011 FY	-135.13 Million INR	-481.94%
2010 FY	35.38 Million INR	88.5%
2009 FY	18.76 Million INR	-0.19%
2008 FY	18.8 Million INR	15.87%
2007 FY	16.22 Million INR	421.35%
2006 FY	3.11 Million INR	0.0%

Peer Operating Expenses Comparison of Transgene Biotek Limited

Name	Operating Expenses	Operating Expenses Difference
Alfavision Overseas (India) Limited	1.24 Million INR	-335.242%
Biocon Limited	40.9 Billion INR	99.987%
Blue Jet Healthcare Limited	531.85 Million INR	98.985%
Concord Biotech Limited	1.45 Billion INR	99.63%
Dishman Carbogen Amcis Limited	5.14 Billion INR	99.895%
FERMENTA BIOTECH LIMITED	754.2 Million INR	99.284%
GENOMIC VALLEY BIOTECH LIMITED	375 Thousand INR	-1339.2%
Lyka Labs Limited	599.4 Million INR	99.1%
Panacea Biotec Limited	1.99 Billion INR	99.73%
SAMSRITA LABS LIMITED	1.49 Million INR	-260.43%
Servoteach Industries Limited	785.00 INR	-687415.924%
SMS Lifesciences India Limited	602.96 Million INR	99.105%
Supriya Lifescience Limited	1.08 Billion INR	99.5%
Syngene International Limited	5.99 Billion INR	99.91%
TAKE Solutions Limited	396.91 Million INR	98.64%
Titan Biotech Limited	117.05 Million INR	95.389%
Vanta Bioscience Limited	38.95 Million INR	86.147%